ALK-Abelló A/S (ALK-B.CO)

101.50 +0.50 (+0.50%) At close: 04:59PM CET

ALK-Abelló A/S

Boge Alle 6-8
Horsholm 2970
Denmark
45 45 74 75 76
https://www.alk.net

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 2,587

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Carsten Hellmann	Pres, CEO & Member of Management Board	14.45M	N/A	1964
Mr. Søren Jelert	Group CFO, Exec. VP & Member of Management Board	6.14M	N/A	1972
Mr. Henrik Jacobi	Exec. VP of R&D and Member of Board of Management	5.37M	N/A	1965
Mr. Søren Daniel Niegel	Exec. VP of Commercial Operations & Member of Management Board	5.34M	N/A	1971
Ms. Katja Barnkob Thalund	Project Director of Global CMC Devel. & Employee-elected Director	300k	N/A	1969
Mr. Per Plotnikof	VP of Corp. Communications, Investor Relations & Strategic Planning and Head of IR	N/A	N/A	N/A
Prof. Hendrik Kees Kam Nolte M.D., Ph.D.	Sr. VP of Research & Devel. - North America and International Markets	N/A	N/A	N/A
Mr. Christian G. Houghton	Head of Product Supply	N/A	N/A	N/A
Mr. Miles Guralnick	Pres of ALK Abelló Source Materials Inc	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.

Description

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

Corporate governance

ALK-Abelló A/S’s ISS governance QualityScore as of 1 October 2022 is 3. The pillar scores are Audit: 1; Board: 4; Shareholder rights: 9; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.